Skip to main content
OpenTrials

Clinical trial condition

Systemic Juvenile Idiopathic Arthritis

Explore clinical trials studying Systemic Juvenile Idiopathic Arthritis. Study availability and eligibility vary by location and protocol.

10 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Systemic Juvenile Idiopathic Arthritis trial results

Completed

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.

NCT00891046

Conditions
Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +7 more
Locations
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Louisville, Kentucky, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
  • Novartis Investigative Site Cincinnati, Ohio, United States
View all 73 locations
View Trial Details
Active, Not Recruiting

A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)

NCT04088396

Conditions
Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +11 more
Locations
  • Instituto CAICI SRL Rosario, Argentina
  • Centro Medico Privado de Reumatologia SAN M. de Tucuman, Argentina
  • UZ Gent Ghent, Belgium
  • Faculdade de Medicina da UNESP Botucatu, Brazil
View all 55 locations
View Trial Details

Related conditions